end,filed,form,Name,Ticker,CIK,Currency,AccountsAndOtherReceivablesNetCurrent,AccountsPayableAndOtherAccruedLiabilitiesCurrent,AccountsPayableTradeCurrent,AccruedBonusesCurrent,AccruedProfessionalFeesCurrent,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,AccumulatedOtherComprehensiveIncomeLossNetOfTax,AdditionalPaidInCapitalCommonStock,AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue,AllocatedShareBasedCompensationExpense,AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount,Assets,AssetsCurrent,CashAndCashEquivalentsAtCarryingValue,CashAndCashEquivalentsPeriodIncreaseDecrease,CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,ClassOfWarrantOrRightOutstanding,CommonStockParOrStatedValuePerShare,CommonStockSharesAuthorized,CommonStockSharesIssued,CommonStockSharesOutstanding,CommonStockValue,ComprehensiveIncomeNetOfTax,ContractWithCustomerAssetNetCurrent,DeferredIncomeTaxLiabilities,DeferredTaxAssetsCapitalLossCarryforwards,DeferredTaxAssetsGoodwillAndIntangibleAssets,DeferredTaxAssetsGross,DeferredTaxAssetsLiabilitiesNet,DeferredTaxAssetsNet,DeferredTaxAssetsOperatingLossCarryforwards,DeferredTaxAssetsOther,DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost,DeferredTaxAssetsValuationAllowance,DeferredTaxLiabilitiesLeasingArrangements,DeferredTaxLiabilitiesPrepaidExpenses,DeferredTaxLiabilitiesPropertyPlantAndEquipment,DepositAssets,Depreciation,DepreciationDepletionAndAmortization,DueFromBanks,EarningsPerShareBasicAndDiluted,EffectiveIncomeTaxRateContinuingOperations,EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance,EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential,EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment,EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent,EffectiveIncomeTaxRateReconciliationTaxCreditsResearch,EffectOfExchangeRateOnCashAndCashEquivalents,EmployeeRelatedLiabilitiesCurrent,EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized,ForeignCurrencyExchangeRateTranslation1,ForeignCurrencyTransactionGainLossBeforeTax,GainLossOnSaleOfPropertyPlantEquipment,GeneralAndAdministrativeExpense,GrantsReceivableCurrent,IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic,IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign,IncreaseDecreaseInAccountsAndOtherReceivables,IncreaseDecreaseInEmployeeRelatedLiabilities,IncreaseDecreaseInOtherOperatingAssets,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,InterestIncomeExpenseNonoperatingNet,LesseeOperatingLeaseDiscountRate,LesseeOperatingLeaseLiabilityPaymentsDue,LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths,LesseeOperatingLeaseLiabilityPaymentsDueYearThree,LesseeOperatingLeaseLiabilityPaymentsDueYearTwo,LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear,LesseeOperatingLeaseLiabilityUndiscountedExcessAmount,Liabilities,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInOperatingActivities,NetIncomeLoss,NonoperatingIncomeExpense,OperatingExpenses,OperatingIncomeLoss,OperatingLeaseExpense,OperatingLeaseLiability,OperatingLeaseLiabilityCurrent,OperatingLeaseLiabilityNoncurrent,OperatingLeasePayments,OperatingLeaseRightOfUseAsset,OperatingLeaseRightOfUseAssetAmortizationExpense,OperatingLeasesRentExpenseNet,OtherAccruedLiabilitiesCurrent,OtherAssets,OtherAssetsCurrent,OtherAssetsNoncurrent,OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax,OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent,OtherNonoperatingIncomeExpense,OtherReceivablesNetCurrent,PaymentsOfStockIssuanceCosts,PaymentsToAcquirePropertyPlantAndEquipment,PrepaidExpenseAndOtherAssetsCurrent,PrepaidExpenseCurrent,ProceedsFromIssuanceInitialPublicOffering,ProceedsFromIssuanceOfCommonStock,ProceedsFromSaleOfPropertyPlantAndEquipment,PropertyPlantAndEquipmentGross,PropertyPlantAndEquipmentNet,ResearchAndDevelopmentExpense,RetainedEarningsAccumulatedDeficit,RevenueFromContractWithCustomerIncludingAssessedTax,RevenueNotFromContractWithCustomerOther,Revenues,RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability,SaleOfStockNumberOfSharesIssuedInTransaction,SecurityDeposit,ShareBasedCompensation,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue,SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit,StockholdersEquity,StockIssuedDuringPeriodValueNewIssues,TimeDepositsAtCarryingValue,UnrealizedGainLossOnInvestments,UnrecognizedTaxBenefits,ValuationAllowanceDeferredTaxAssetChangeInAmount,WeightedAverageNumberOfShareOutstandingBasicAndDiluted,AccruedBonusesCurrentAndNoncurrent
2020-06-30,2020-09-23,10-K,BENITEC BIOPHARMA INC.,BNTC,CIK0001808898,USD,59000.0,741000.0,282000.0,,155000.0,796000.0,-1953000.0,128827000.0,237000.0,237000.0,215578.0,11587000.0,10809000.0,9801000.0,,-5859000.0,,145424.0,0.0001,10000000.0,1108374.0,1108374.0,0.0,-8363000.0,0.0,157000.0,,0.0,13447000.0,0.0,157000.0,13153000.0,209000.0,0.0,13290000.0,83000.0,0.0,74000.0,9000.0,45000.0,190000.0,5231000.0,-8.1,0.0,0.21,-0.2412,0.0626,,-0.0074,,-58000.0,203000.0,242000.0,0.6877,-88000.0,-1000.0,5567000.0,,-299000.0,-7975000.0,-2396000.0,57000.0,457000.0,457000.0,62000.0,0.0467,425000.0,207000.0,,218000.0,,20000.0,1349000.0,11587000.0,1136000.0,1770000.0,-94000.0,-7535000.0,-8274000.0,7000.0,8383000.0,-8281000.0,,405000.0,192000.0,213000.0,174000.0,395000.0,184000.0,,201000.0,949000.0,949000.0,,-89000.0,-89000.0,34000.0,59000.0,480000.0,95000.0,949000.0,861000.0,,2250000.0,1000.0,1170000.0,374000.0,3001000.0,-116636000.0,97000.0,5000.0,102000.0,579000.0,,69000.0,237000.0,1.041,1.029,0.0167,0.0128,0.0,0.0,10238000.0,1720000.0,4570000.0,-1000.0,0.0,2215.0,1021193.0,
2020-09-30,2020-11-13,10-Q,BENITEC BIOPHARMA INC.,BNTC,CIK0001808898,USD,18000.0,624000.0,299000.0,,43000.0,841000.0,-1775000.0,128850000.0,38000.0,38000.0,145421.0,8916000.0,8056000.0,7450000.0,,-2533000.0,-2351000.0,107098.0,0.0001,10000000.0,1108374.0,1108374.0,1000.0,-2540000.0,,,,,,,,,,,,,,,9000.0,45000.0,45000.0,7450000.0,-2.45,,,,,,,,182000.0,197000.0,119000.0,,-54000.0,,1837000.0,,,,-27000.0,-8000.0,-374000.0,,-1000.0,0.0467,375000.0,156000.0,,218000.0,,16000.0,1180000.0,8916000.0,1019000.0,,-173000.0,-2360000.0,-2718000.0,-28000.0,2745000.0,-2690000.0,100000.0,359000.0,198000.0,161000.0,,348000.0,,52000000.0,111000.0,,588000.0,,178000.0,178000.0,27000.0,,,173000.0,,564000.0,,,,1344000.0,503000.0,774000.0,-119340000.0,55000.0,,55000.0,0.0,,14000.0,38000.0,,,,,,,7736000.0,,0.0,0.0,,,1108374.0,
2020-12-31,2021-02-09,10-Q,BENITEC BIOPHARMA INC.,BNTC,CIK0001808898,USD,21000.0,355000.0,87000.0,,35000.0,908000.0,-1567000.0,138395000.0,82000.0,82000.0,,15512000.0,14383000.0,14010000.0,,,,384679.0,0.0001,10000000.0,4540469.0,4540469.0,4000.0,-3044000.0,,,,,,,,,,,,,,,9000.0,67000.0,,14010000.0,-0.76,,,,,,,,,221000.0,1393000.0,,0.0,,2111000.0,,,,,,,,-2000.0,0.0467,323000.0,105000.0,,218000.0,,12000.0,887000.0,15512000.0,779000.0,,,,-3252000.0,7000.0,3260000.0,-3259000.0,,311000.0,203000.0,108000.0,,300000.0,,52000000.0,91000.0,562000.0,352000.0,210000.0,208000.0,208000.0,10000.0,21000.0,1643000.0,,,538000.0,,,,1518000.0,610000.0,1168000.0,-122207000.0,1000.0,,1000.0,,,16000.0,,,,,,,,14625000.0,,0.0,-1000.0,,,4300073.0,
2021-03-31,2021-05-12,10-Q,BENITEC BIOPHARMA INC.,BNTC,CIK0001808898,USD,10000.0,2005000.0,1640000.0,,42000.0,972000.0,-1591000.0,138632000.0,235000.0,235000.0,,13428000.0,12407000.0,11988000.0,,,,107098.0,0.0001,10000000.0,4818050.0,4818050.0,5000.0,-3933000.0,,,,,,,,,,,,,,,9000.0,67000.0,,11988000.0,-0.82,,,,,,,,,231000.0,1159000.0,,-112000.0,,1029000.0,,,,,,,,-2000.0,0.0467,270000.0,52000.0,,218000.0,,8000.0,2498000.0,13428000.0,2444000.0,,,,-3909000.0,-116000.0,3794000.0,-3793000.0,,262000.0,208000.0,54000.0,,252000.0,,52000000.0,181000.0,606000.0,409000.0,197000.0,-24000.0,-24000.0,,,,,,587000.0,,,,1535000.0,563000.0,2758000.0,-126116000.0,1000.0,,1000.0,,,15000.0,,,,,,,,10930000.0,,0.0,-2000.0,,,4747059.0,
2021-06-30,2021-09-20,10-K,BENITEC BIOPHARMA INC.,BNTC,CIK0001808898,USD,25000.0,880000.0,274000.0,,13000.0,1018000.0,-1455000.0,151583000.0,634000.0,634000.0,809159.0,21379000.0,20608000.0,19769000.0,,9469000.0,,107095.0,0.0001,40000000.0,8171690.0,8171690.0,1000.0,-13384000.0,,254000.0,,212000.0,16477000.0,0.0,254000.0,15902000.0,230000.0,88000.0,16223000.0,42000.0,136000.0,76000.0,9000.0,231000.0,231000.0,19769000.0,-3.23,0.0,0.21,-0.139,0.0212,,-0.0032,,499000.0,276000.0,1266000.0,0.7506,-333000.0,,6512000.0,,-7911000.0,-5971000.0,-28000.0,121000.0,,4000.0,-6000.0,0.0467,,218000.0,,,,5000.0,1369000.0,21379000.0,1369000.0,22522000.0,-221000.0,-12832000.0,-13882000.0,-286000.0,13655000.0,-13596000.0,,213000.0,213000.0,0.0,192000.0,202000.0,193000.0,,174000.0,999000.0,814000.0,185000.0,498000.0,498000.0,37000.0,,3228000.0,221000.0,814000.0,967000.0,,25750000.0,,1393000.0,375000.0,7020000.0,-130119000.0,59000.0,,59000.0,,,15000.0,634000.0,1.274,1.12,0.0055,0.0044,2.68,0.0,20010000.0,22519000.0,,16000.0,0.0,2933.0,4295416.0,0.0
2021-09-30,2021-11-15,10-Q,BENITEC BIOPHARMA INC.,BNTC,CIK0001808898,USD,3000.0,1106000.0,323000.0,112000.0,99000.0,1069000.0,-1216000.0,151854000.0,271000.0,271000.0,809159.0,17836000.0,16372000.0,15727000.0,,,-4042000.0,107095.0,0.0001,10000000.0,8171690.0,8171690.0,1000.0,-4806000.0,,,,,,,,,,,,,,,25000.0,100000.0,52000.0,15727000.0,-0.62,,,,,,,,236000.0,301000.0,1000000.0,,-240000.0,,2042000.0,,,,0.0,-8000.0,-179000.0,,-1000.0,0.0467,1047000.0,287000.0,228000.0,297000.0,235000.0,93000.0,2361000.0,17836000.0,1601000.0,,0.0,-4278000.0,-5045000.0,-223000.0,4822000.0,-4822000.0,100000.0,954000.0,194000.0,760000.0,51000.0,947000.0,49000.0,,86000.0,811000.0,642000.0,169000.0,239000.0,239000.0,,,,0.0,642000.0,763000.0,,,,1392000.0,323000.0,2780000.0,-135164000.0,0.0,,0.0,794000.0,,14000.0,271000.0,,,,,,,15475000.0,,,18000.0,,,8171690.0,
2021-12-31,2022-02-14,10-Q,BENITEC BIOPHARMA INC.,BNTC,CIK0001808898,USD,5000.0,1946000.0,682000.0,,55000.0,1124000.0,-1273000.0,152093000.0,239000.0,239000.0,,14014000.0,12672000.0,12329000.0,,,,107095.0,0.0001,40000000.0,8171690.0,8171690.0,1000.0,-4878000.0,,,,,,,,,,,,,,,25000.0,55000.0,,,-0.59,,,,,,,,,321000.0,800000.0,,48000.0,,1714000.0,,,,,,,,-11000.0,0.0467,993000.0,290000.0,152000.0,300000.0,251000.0,82000.0,3178000.0,14014000.0,2480000.0,,,,-4821000.0,14000.0,4860000.0,-4835000.0,100000.0,911000.0,213000.0,698000.0,,888000.0,,,223000.0,499000.0,338000.0,161000.0,-57000.0,-57000.0,0.0,,,,338000.0,472000.0,,,,1392000.0,268000.0,3146000.0,-139985000.0,25000.0,,25000.0,,,15000.0,,,,,,,,10836000.0,,,-23000.0,,,8171690.0,112000.0
